CVS to pay $20 million for misleading investors, improper accounting

The SEC said CVS defrauded investors through during a 2009 debt offering and conducted improper accounting in an acquisition

CVS: For all the ways you care... about things other than proper accounting practices.

CVS Caremark Corp. announced on April 8 that it will pay $20 million to settle Securities and Exchange Commission (SEC) accusations that it defrauded investors during a 2009 debt offering and conducted improper accounting through its acquisition of Longs Drug Stores Corp.

Assistant Editor

author image

Zach Warren

Zach Warren is Assistant Editor of InsideCounsel magazine, where he oversees online content submissions and administers InsideCounsel's enewsletters. Zach specializes in new media and multimedia...

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.